We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $195M
1-Year Est. Return 15.9%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+15.9%
3 Year Est. Return
+50.57%
5 Year Est. Return
10 Year Est. Return
AUM
$202M
AUM Growth
+$17.7M
Cap. Flow
+$15M
Cap. Flow %
7.43%
Top 10 Hldgs %
37.46%
Holding
210
New
34
Increased
96
Reduced
62
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 9.1%
2 Technology 8.73%
3 Consumer Discretionary 7.74%
4 Financials 7.45%
5 Energy 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBSF icon
1
Regan Floating Rate MBS ETF
MBSF
$229M
$28.2M 13.99%
1,101,138
+32,598
+3% +$834K
MBSX
2
Regan Fixed Rate MBS ETF
MBSX
$18.6M
$7.7M 3.82%
291,806
+17,688
+6% +$473K
AAPL icon
3
Apple
AAPL
$4.9T
$6.62M 3.28%
24,351
-12,700
-34% -$3.41M
COP icon
4
ConocoPhillips
COP
$140B
$6.14M 3.04%
65,642
+14,992
+30% +$1.36M
HD icon
5
Home Depot
HD
$338B
$4.88M 2.42%
14,170
+3,232
+30% +$1.18M
BMY icon
6
Bristol-Myers Squibb
BMY
$124B
$4.61M 2.29%
85,542
+11,504
+16% +$553K
LST
7
Leuthold Select Industries ETF
LST
$112M
$4.54M 2.25%
113,005
+9,487
+9% +$377K
TSLA icon
8
Tesla
TSLA
$1.43T
$4.43M 2.19%
9,848
+1,358
+16% +$602K
SPY icon
9
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$4.27M 2.12%
6,267
+474
+8% +$320K
JPST icon
10
JPMorgan Ultra-Short Income ETF
JPST
$39.8B
$4.16M 2.06%
82,285
+12,764
+18% +$647K
AMGN icon
11
Amgen
AMGN
$198B
$4.13M 2.05%
12,623
+948
+8% +$301K
ARP icon
12
PMV Adaptive Risk Parity ETF
ARP
$66.5M
$3.54M 1.75%
117,141
-672
-0.6% -$21.2K
FDVV icon
13
Fidelity High Dividend ETF
FDVV
$10B
$3.49M 1.73%
61,605
+2,661
+5% +$150K
UNH icon
14
UnitedHealth
UNH
$387B
$2.97M 1.47%
9,001
+1,307
+17% +$443K
RAAX icon
15
VanEck Inflation Allocation ETF
RAAX
$1.28B
$2.61M 1.29%
+74,613
New +$2.62M
KKR icon
16
KKR & Co
KKR
$90.6B
$2.54M 1.26%
+19,924
New +$2.48M
FELG icon
17
Fidelity Enhanced Large Cap Growth ETF
FELG
$5.5B
$2.43M 1.2%
58,251
-6,209
-10% -$258K
MSFT icon
18
Microsoft
MSFT
$2.93T
$2.18M 1.08%
4,505
+255
+6% +$128K
SPYD icon
19
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
$2.14M 1.06%
49,517
+186
+0.4% +$8.06K
JQC icon
20
Nuveen Credit Strategies Income Fund
JQC
$702M
$2.07M 1.03%
412,416
+189,677
+85% +$964K
QLD icon
21
ProShares Ultra QQQ
QLD
$13B
$2.01M 0.99%
28,482
-10,986
-28% -$779K
VOO icon
22
Vanguard S&P 500 ETF
VOO
$974B
$1.92M 0.95%
3,061
-888
-22% -$552K
ELV icon
23
Elevance Health
ELV
$80.9B
$1.9M 0.94%
5,406
-1,237
-19% -$418K
AMZN icon
24
Amazon
AMZN
$2.66T
$1.85M 0.92%
8,009
-279
-3% -$63.8K
FSCO
25
FS Credit Opportunities Corp
FSCO
$993M
$1.85M 0.92%
293,178
+182,496
+165% +$1.17M

Similar funds

Castleview Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Castleview Partners held 210 positions worth $202M, up 9.6% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Castleview Partners deployed $15M of net new capital in Q4 2025, opening 34 new positions and adding to 96 existing holdings. Its largest new stake was VanEck Inflation Allocation ETF: 74,613 shares worth $2.61M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $3.41M trimmed.

  • Castleview Partners's largest Q4 2025 buy was VanEck Inflation Allocation ETF: 74,613 shares worth $2.61M.
  • Castleview Partners added most to ConocoPhillips in Q4 2025, an estimated $1.36M increase.
  • Castleview Partners's biggest Q4 2025 reduction was Apple, cutting an estimated $3.41M.
  • Castleview Partners fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $509K.
  • Castleview Partners's ten largest holdings make up 37% of its $202M portfolio in Q4 2025.
  • Castleview Partners opened 34 new positions and closed 13 in Q4 2025.
  • Castleview Partners's portfolio value rose 9.6% quarter-over-quarter to $202M.

Based on Castleview Partners's 13F filing for Q4 2025, filed 12 Jan 2026.